INSP Stock: Price, Earnings History and SEC Filings
Inspire Medical Systems, Inc. (INSP) last traded at $68.10, down 4.33% on the latest session and down 1.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.14 against an analyst estimate of $-0.22, a beat of 163.6%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
INSP earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 3, 2026 | $0.14 | $-0.22 | +163.64% |
| Mar 2026 | May 4, 2026 | $0.10 | $-0.36 | +127.78% |
| Dec 2025 | Feb 11, 2026 | $1.65 | $0.69 | +139.13% |
| Sep 2025 | Nov 3, 2025 | $0.38 | $-0.15 | +353.33% |
INSP beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How INSP reacts to earnings
Across its last 8 earnings releases, INSP moved 12.9% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-03 | After close | +22.83% |
| 2026-05-04 | After close | -12.02% |
| 2026-02-11 | After close | -12.55% |
| 2026-01-12 | After close | -4.61% |
| 2025-11-03 | After close | +15.33% |
| 2025-08-04 | After close | -32.35% |
| 2025-05-05 | After close | +1.98% |
| 2025-02-10 | After close | +1.66% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
INSP financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $912M | $145M | $78M | 15.9% | $4.89 |
| 2024 | $803M | $54M | $91M | 6.7% | $1.75 |
| 2023 | $625M | -$21M | $1M | -3.4% | $-0.72 |
| 2022 | $408M | -$45M | $2M | -11.0% | $-1.60 |
| 2021 | $233M | -$42M | -$25M | -18.0% | $-1.54 |
| 2020 | $115M | -$57M | -$56M | -49.6% | $-2.19 |
| 2019 | $82M | -$33M | -$36M | -40.5% | $-1.40 |
| 2018 | $51M | -$22M | -$19M | -43.1% | – |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for INSP
- 10-Q · Aug 3, 2026
- 8-K · Aug 3, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Jul 24, 2026Officer or director change
- 8-K · Jul 22, 2026Officer or director change, Financial statements and exhibits
- 8-K · Jun 26, 2026Regulation FD disclosure, Financial statements and exhibits
- 8-K · May 5, 2026Officer or director change, Bylaw change, Shareholder vote
- 10-Q · May 4, 2026
- 8-K · May 4, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- DEF 14A · Mar 20, 2026
- 10-K · Feb 13, 2026
Insider filing activity
INSP insiders filed 7 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
INSP news
- 2 high-flying stocks on our watchlist and 1 we turn downOct 30, 2026 · finance.yahoo.com
- Inspire Medical Systems IncOct 30, 2026 · 247wallst.com
- 3 healthcare stocks we keep off our radarOct 26, 2026 · finance.yahoo.com
- INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?Oct 23, 2026 · finance.yahoo.com
- Here's How Tempus AI Demonstrates Improving Operating LeverageOct 19, 2026 · finance.yahoo.com
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. (INSP) is a US-listed public company on NYSE. The SEC classifies its business as Surgical & Medical Instruments & Apparatus. It is incorporated in DE. Its fiscal year ends in December.